Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Kyverna Therapeutics, Inc.
KYTX · Transcripts
website
149
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell t...
Price
5.17
Market Cap
314.34 M
Float
50.42 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about KYTX
Kyverna Therapeutics, Inc.
KYTX · Transcripts
50.42 M
Float
5.17
Price
314.34 M
Market Cap
2024
AI
Type
Title
Quarter
Created Date
2023
AI
Type
Title
Quarter
Created Date
2022
AI
Type
Title
Quarter
Created Date
2021
AI
Type
Title
Quarter
Created Date